Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2018-11-07
2018-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Biotin on Routine Laboratory Values
NCT03995277
Biotin Status in Pregnancy
NCT00894920
Study of ORL-1B in Patients With Biotinidase Deficiency
NCT03269045
Vitamin B12 Biomarker Responses to Supplementation
NCT04731948
Vitamin B12 Supplementation Study
NCT00826657
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each volunteer will be asked to read the volunteer information sheet and if they wish to participate in the study, the study admission form will be completed and the volunteer will be asked to sign a consent form.
After informed consent each volunteer will be assigned a unique volunteer number for the duration of the trial to provide anonymity. The volunteer will be provided with a daily diary, urine collection material and a full set of volunteer instructions.
The daily diary will collect the following information;
* Date
* Whether or not supplement was taken and time taken
* sample collection times during the day
Volunteers will be requested to:
Day 1: Collect a urine sample from every void during the day. Days 2-6: Take biotin supplements with their evening meal and collect a urine sample from every void during the day Day 7: Collect a urine sample from every void during the day
All samples will be stored in the SPD Bio-bank until required for analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biotin
Volunteers to take biotin suppliment
Biotin
Biotin supplements (2) to be taken daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biotin
Biotin supplements (2) to be taken daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has regular menstrual periods
* SPD employee or partner of SPD employee
Exclusion Criteria
* Taken Antibiotics in the last 4 weeks
* Diagnosed with metabolic disorder, kidney or liver disease
* Known Pregnancy or seeking to conceive
* Breast feeding
* Undergoing medical investigation for hormone imbalance
* Condition that contra-indicates pregnancy
* Condition that contra-indicates use of biotin supplements
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SPD Development Company Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Johnson, Dr
Role: STUDY_DIRECTOR
SPD Development company Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SPD Development Company Ltd
Bedford, Bedfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROTOCOL-1001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.